Extraordinary science to life changing therapies: Leading the translation of RNA-modifying protein (RMP) biology into promising new therapies for cancer.

Biotechnology

Accent Therapeutics

Shakti Narayan

Kevin McGann, CPA

Steven Mennen

Shane Buker

Kevin Knockenhauer

Jennifer Castro

Brian Sparling

Jie Wu

Maureen Lynes

Julie Liu

Gina Prophete

David Brower

Robert A. Copeland

Stephen Blakemore

Ann Boriack-Sjodin

The Research and Development team at Accent Therapeutics is focused on advancing the understanding and application of RNA-modifying proteins (RMP) in oncology. They collaborate across molecular discovery, translational medicine, pre-clinical development, biology, chemistry, and bioinformatics to innovate and develop new cancer therapies.

Research and Development

Directors and Associate Directors

Scientific Research

Scientific Advisors

Research and Development

About

Team members

Other teams at Accent Therapeutics

Directors and Associate Directors

Scientific Research

Scientific Advisors